{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T19:31:18Z","timestamp":1742931078573,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":99,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493933457"},{"type":"electronic","value":"9781493933471"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3347-1_16","type":"book-chapter","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T04:04:49Z","timestamp":1456286689000},"page":"281-298","source":"Crossref","is-referenced-by-count":0,"title":["Proteomics in the Assessment of the Therapeutic Response of Antineoplastic Drugs: Strategies and Practical Applications"],"prefix":"10.1007","author":[{"given":"Vukosava Milic","family":"Torres","sequence":"first","affiliation":[]},{"given":"Lazar","family":"Popovic","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Vaz","sequence":"additional","affiliation":[]},{"given":"Deborah","family":"Penque","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,2,25]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1559-0275-10-13","volume":"10","author":"AK Fuzery","year":"2013","unstructured":"Fuzery AK, Levin J, Chan MM, Chan DW (2013) Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges. Clin Proteomics 10:13","journal-title":"Clin Proteomics"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1586\/14789450.2014.897614","volume":"11","author":"D Li","year":"2014","unstructured":"Li D, Chan DW (2014) Proteomic cancer biomarkers from discovery to approval: it\u2019s worth the effort. Expert Rev Proteomics 11:135\u2013136","journal-title":"Expert Rev Proteomics"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1002\/art.20796","volume":"50","author":"SD Patterson","year":"2004","unstructured":"Patterson SD (2004) Proteomics: beginning to realize its promise? Arthritis Rheum 50:3741\u20133744","journal-title":"Arthritis Rheum"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nature01511","volume":"422","author":"R Aebersold","year":"2003","unstructured":"Aebersold R, Mann M (2003) Mass spectrometry-based proteomics. Nature 422:198\u2013207","journal-title":"Nature"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/prca.200800025","volume":"3","author":"D Penque","year":"2009","unstructured":"Penque D (2009) Two-dimensional gel electrophoresis and mass spectrometry for biomarker discovery. Proteomics Clin Appl 3:155\u2013172","journal-title":"Proteomics Clin Appl"},{"key":"16_CR6","series-title":"Methods in molecular biology","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-62703-739-6_2","volume-title":"Molecular toxicology protocols","author":"W Gao","year":"2014","unstructured":"Gao W (2014) Analysis of protein changes using two-dimensional difference gel electrophoresis. In: Keohavong P, Grant SG (eds) Molecular toxicology protocols, vol 1105, Methods in molecular biology. Humana, New York, NY, pp 17\u201330, doi: 10.1007\/978-1-62703-739-6_2"},{"key":"16_CR7","first-page":"9","volume":"1","author":"F Dautel","year":"2011","unstructured":"Dautel F, Kalkhof S, Trump S, Lehmann I, Beyer A, Martin VB (2011) Large-scale 2-D DIGE studies \u2013 guidelines to overcome pitfalls and challenges along the experimental procedure. J Integr OMICS 1:9","journal-title":"J Integr OMICS"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1021\/cr3003533","volume":"113","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Fonslow BR, Shan B, Baek MC, Yates JR 3rd (2013) Protein analysis by shotgun\/bottom-up proteomics. Chem Rev 113:2343\u20132394","journal-title":"Chem Rev"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-1-62703-392-3_5","volume":"1007","author":"R Matthiesen","year":"2013","unstructured":"Matthiesen R (2013) Algorithms for database-dependent search of MS\/MS data. Methods Mol Biol 1007:119\u2013138","journal-title":"Methods Mol Biol"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1016\/j.jprot.2012.05.010","volume":"75","author":"R Matthiesen","year":"2012","unstructured":"Matthiesen R, Prieto G, Amorim A, Aloria K, Fullaondo A, Carvalho AS, Arizmendi JM (2012) SIR: deterministic protein inference from peptides assigned to MS data. J Proteomics 75:4176\u20134183","journal-title":"J Proteomics"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1074\/mcp.T400006-MCP200","volume":"3","author":"S Carr","year":"2004","unstructured":"Carr S, Aebersold R, Baldwin M, Burlingame A, Clauser K, Nesvizhskii A (2004) The need for guidelines in publication of peptide and protein identification data: working group on publication guidelines for peptide and protein identification data. Mol Cell Proteomics 3:531\u2013533","journal-title":"Mol Cell Proteomics"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1074\/mcp.R500012-MCP200","volume":"4","author":"AI Nesvizhskii","year":"2005","unstructured":"Nesvizhskii AI, Aebersold R (2005) Interpretation of shotgun proteomic data: the protein inference problem. Mol Cell Proteomics 4:1419\u20131440","journal-title":"Mol Cell Proteomics"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1477-5956-4-8","volume":"4","author":"M Latterich","year":"2006","unstructured":"Latterich M (2006) Publishing proteomic data. Proteome Sci 4:8","journal-title":"Proteome Sci"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/pmic.200500856","volume":"6","author":"MR Wilkins","year":"2006","unstructured":"Wilkins MR, Appel RD, Van Eyk JE, Chung MC, Gorg A, Hecker M, Huber LA, Langen H, Link AJ, Paik YK, Patterson SD, Pennington SR, Rabilloud T, Simpson RJ, Weiss W, Dunn MJ (2006) Guidelines for the next 10 years of proteomics. Proteomics 6:4\u20138","journal-title":"Proteomics"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1021\/pr700728t","volume":"7","author":"DL Tabb","year":"2008","unstructured":"Tabb DL (2008) What\u2019s driving false discovery rates? J Proteome Res 7:45\u201346","journal-title":"J Proteome Res"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nbt0808-862","volume":"26","author":"PA Binz","year":"2008","unstructured":"Binz PA, Barkovich R, Beavis RC, Creasy D, Horn DM, Julian RK Jr, Seymour SL, Taylor CF, Vandenbrouck Y (2008) Guidelines for reporting the use of mass spectrometry informatics in proteomics. Nat Biotechnol 26:862","journal-title":"Nat Biotechnol"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/pmic.201000404","volume":"11","author":"R Matthiesen","year":"2011","unstructured":"Matthiesen R, Azevedo L, Amorim A, Carvalho AS (2011) Discussion on common data analysis strategies used in MS-based proteomics. Proteomics 11:604\u2013619","journal-title":"Proteomics"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/13690","volume":"17","author":"SP Gygi","year":"1999","unstructured":"Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17:994\u2013999","journal-title":"Nat Biotechnol"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1021\/ac0256991","volume":"74","author":"PV Bondarenko","year":"2002","unstructured":"Bondarenko PV, Chelius D, Shaler TA (2002) Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Anal Chem 74:4741\u20134749","journal-title":"Anal Chem"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1021\/pr025517j","volume":"1","author":"D Chelius","year":"2002","unstructured":"Chelius D, Bondarenko PV (2002) Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J Proteome Res 1:317\u2013323","journal-title":"J Proteome Res"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1021\/ac0498563","volume":"76","author":"H Liu","year":"2004","unstructured":"Liu H, Sadygov RG, Yates JR 3rd (2004) A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 76:4193\u20134201","journal-title":"Anal Chem"},{"key":"16_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1586\/epr.09.69","volume":"7","author":"DH Lundgren","year":"2010","unstructured":"Lundgren DH, Hwang SI, Wu L, Han DK (2010) Role of spectral counting in quantitative proteomics. Expert Rev Proteomics 7:39\u201353","journal-title":"Expert Rev Proteomics"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/pmic.201000553","volume":"11","author":"KA Neilson","year":"2011","unstructured":"Neilson KA, Ali NA, Muralidharan S, Mirzaei M, Mariani M, Assadourian G, Lee A, van Sluyter SC, Haynes PA (2011) Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 11:535\u2013553","journal-title":"Proteomics"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1021\/pr050405o","volume":"5","author":"WW Wu","year":"2006","unstructured":"Wu WW, Wang G, Baek SJ, Shen RF (2006) Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF\/TOF. J Proteome Res 5:651\u2013658","journal-title":"J Proteome Res"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1074\/mcp.M200025-MCP200","volume":"1","author":"SE Ong","year":"2002","unstructured":"Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1:376\u2013386","journal-title":"Mol Cell Proteomics"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1074\/mcp.M400129-MCP200","volume":"3","author":"PL Ross","year":"2004","unstructured":"Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3:1154\u20131169","journal-title":"Mol Cell Proteomics"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1021\/ac0262560","volume":"75","author":"A Thompson","year":"2003","unstructured":"Thompson A, Schafer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, Neumann T, Johnstone R, Mohammed AK, Hamon C (2003) Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS\/MS. Anal Chem 75:1895\u20131904","journal-title":"Anal Chem"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1021\/ac702422x","volume":"80","author":"L Dayon","year":"2008","unstructured":"Dayon L, Hainard A, Licker V, Turck N, Kuhn K, Hochstrasser DF, Burkhard PR, Sanchez JC (2008) Relative quantification of proteins in human cerebrospinal fluids by MS\/MS using 6-plex isobaric tags. Anal Chem 80:2921\u20132931","journal-title":"Anal Chem"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.bbapap.2013.04.001","volume":"1834","author":"DA Megger","year":"2013","unstructured":"Megger DA, Bracht T, Meyer HE, Sitek B (2013) Label-free quantification in clinical proteomics. Biochim Biophys Acta 1834:1581\u20131590","journal-title":"Biochim Biophys Acta"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1074\/mcp.M500331-MCP200","volume":"5","author":"L Anderson","year":"2006","unstructured":"Anderson L, Hunter CL (2006) Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 5:573\u2013588","journal-title":"Mol Cell Proteomics"},{"key":"16_CR31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nmeth.2015","volume":"9","author":"P Picotti","year":"2012","unstructured":"Picotti P, Aebersold R (2012) Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 9:555\u2013566","journal-title":"Nat Methods"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1021\/bi400110b","volume":"52","author":"DC Liebler","year":"2013","unstructured":"Liebler DC, Zimmerman LJ (2013) Targeted quantitation of proteins by mass spectrometry. Biochemistry 52:3797\u20133806","journal-title":"Biochemistry"},{"key":"16_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/embor.2008.56","volume":"9","author":"EW Deutsch","year":"2008","unstructured":"Deutsch EW, Lam H, Aebersold R (2008) PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows. EMBO Rep 9:429\u2013434","journal-title":"EMBO Rep"},{"key":"16_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1021\/pr034086h","volume":"3","author":"NL Anderson","year":"2004","unstructured":"Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW (2004) Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J Proteome Res 3:235\u2013244","journal-title":"J Proteome Res"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1021\/ac049880g","volume":"76","author":"EN Warren","year":"2004","unstructured":"Warren EN, Elms PJ, Parker CE, Borchers CH (2004) Development of a protein chip: a MS-based method for quantitation of protein expression and modification levels using an immunoaffinity approach. Anal Chem 76:4082\u20134092","journal-title":"Anal Chem"},{"key":"16_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/rcm.1290060103","volume":"6","author":"RW Nelson","year":"1992","unstructured":"Nelson RW, Hutchens TW (1992) Mass spectrometric analysis of a transition-metal-binding peptide using matrix-assisted leaser-desorption time-of-flight mass spectrometry. A demonstration of probe tip chemistry. Rapid Commun Mass Spectrom 6:4\u20138","journal-title":"Rapid Commun Mass Spectrom"},{"key":"16_CR37","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s13361-011-0094-z","volume":"22","author":"RW Nelson","year":"2011","unstructured":"Nelson RW, Borges CR (2011) Mass spectrometric immunoassay revisited. J Am Soc Mass Spectrom 22:960\u2013968","journal-title":"J Am Soc Mass Spectrom"},{"key":"16_CR38","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/prca.201200028","volume":"7","author":"H Yassine","year":"2013","unstructured":"Yassine H, Borges CR, Schaab MR, Billheimer D, Stump C, Reaven P, Lau SS, Nelson R (2013) Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes. Proteomics Clin Appl 7:528\u2013540","journal-title":"Proteomics Clin Appl"},{"key":"16_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081125","volume":"8","author":"EE Niederkofler","year":"2013","unstructured":"Niederkofler EE, Phillips DA, Krastins B, Kulasingam V, Kiernan UA, Tubbs KA, Peterman SM, Prakash A, Diamandis EP, Lopez MF, Nedelkov D (2013) Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1. PLoS One 8, e81125","journal-title":"PLoS One"},{"key":"16_CR40","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nbt1235","volume":"24","author":"N Rifai","year":"2006","unstructured":"Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971\u2013983","journal-title":"Nat Biotechnol"},{"key":"16_CR41","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/prca.200780174","volume":"2","author":"AG Paulovich","year":"2008","unstructured":"Paulovich AG, Whiteaker JR, Hoofnagle AN, Wang P (2008) The interface between biomarker discovery and clinical validation: the tar pit of the protein biomarker pipeline. Proteomics Clin Appl 2:1386\u20131402","journal-title":"Proteomics Clin Appl"},{"key":"16_CR42","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1021\/pr400132j","volume":"12","author":"SJ Skates","year":"2013","unstructured":"Skates SJ, Gillette MA, LaBaer J, Carr SA, Anderson L, Liebler DC, Ransohoff D, Rifai N, Kondratovich M, Tezak Z, Mansfield E, Oberg AL, Wright I, Barnes G, Gail M, Mesri M, Kinsinger CR, Rodriguez H, Boja ES (2013) Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. J Proteome Res 12:5383\u20135394","journal-title":"J Proteome Res"},{"key":"16_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1373\/clinchem.2012.185801","volume":"59","author":"JP Ioannidis","year":"2013","unstructured":"Ioannidis JP (2013) Biomarker failures. Clin Chem 59:202\u2013204","journal-title":"Clin Chem"},{"key":"16_CR44","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/pmic.200300686","volume":"4","author":"GS Omenn","year":"2004","unstructured":"Omenn GS (2004) The Human Proteome Organization Plasma Proteome Project pilot phase: reference specimens, technology platform comparisons, and standardized data submissions and analyses. Proteomics 4:1235\u20131240","journal-title":"Proteomics"},{"key":"16_CR45","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/prca.200700369","volume":"1","author":"GS Omenn","year":"2007","unstructured":"Omenn GS (2007) THE HUPO Human Plasma Proteome Project. Proteomics Clin Appl 1:769\u2013779","journal-title":"Proteomics Clin Appl"},{"key":"16_CR46","doi-asserted-by":"publisher","first-page":"D959","DOI":"10.1093\/nar\/gkt1251","volume":"42","author":"V Nanjappa","year":"2014","unstructured":"Nanjappa V, Thomas JK, Marimuthu A, Muthusamy B, Radhakrishnan A, Sharma R, Ahmad Khan A, Balakrishnan L, Sahasrabuddhe NA, Kumar S, Jhaveri BN, Sheth KV, Kumar Khatana R, Shaw PG, Srikanth SM, Mathur PP, Shankar S, Nagaraja D, Christopher R, Mathivanan S, Raju R, Sirdeshmukh R, Chatterjee A, Simpson RJ, Harsha HC, Pandey A, Prasad TS (2014) Plasma Proteome Database as a resource for proteomics research: 2014 update. Nucleic Acids Res 42:D959\u2013D965","journal-title":"Nucleic Acids Res"},{"key":"16_CR47","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1021\/pr100646w","volume":"9","author":"C Tu","year":"2010","unstructured":"Tu C, Rudnick PA, Martinez MY, Cheek KL, Stein SE, Slebos RJ, Liebler DC (2010) Depletion of abundant plasma proteins and limitations of plasma proteomics. J Proteome Res 9:4982\u20134991","journal-title":"J Proteome Res"},{"key":"16_CR48","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2014.08.037","volume":"438","author":"Q Wang","year":"2014","unstructured":"Wang Q, Yu Q, Lin Q, Duan Y (2014) Emerging salivary biomarkers by mass spectrometry. Clin Chim Acta 438:214\u2013221","journal-title":"Clin Chim Acta"},{"key":"16_CR49","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000358791","volume":"24","author":"CA Schafer","year":"2014","unstructured":"Schafer CA, Schafer JJ, Yakob M, Lima P, Camargo P, Wong DT (2014) Saliva diagnostics: utilizing oral fluids to determine health status. Monogr Oral Sci 24:88\u201398","journal-title":"Monogr Oral Sci"},{"key":"16_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40496-014-0014-y","volume":"1","author":"M Yakob","year":"2014","unstructured":"Yakob M, Fuentes L, Wang MB, Abemayor E, Wong DT (2014) Salivary biomarkers for detection of oral squamous cell carcinoma \u2013 current state and recent advances. Curr Oral Health Rep 1:133\u2013141","journal-title":"Curr Oral Health Rep"},{"key":"16_CR51","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5005\/jcdp-9-3-72","volume":"9","author":"V Almeida Pdel de","year":"2008","unstructured":"de Almeida Pdel V, Gregio AM, Machado MA, de Lima AA, Azevedo LR (2008) Saliva composition and functions: a comprehensive review. J Contemp Dent Pract 9:72\u201380","journal-title":"J Contemp Dent Pract"},{"key":"16_CR52","doi-asserted-by":"publisher","first-page":"760208","DOI":"10.1155\/2013\/760208","volume":"2013","author":"H Husi","year":"2013","unstructured":"Husi H, Barr JB, Skipworth RJ, Stephens NA, Greig CA, Wackerhage H, Barron R, Fearon KC, Ross JA (2013) The Human Urinary Proteome Fingerprint Database UPdb. Int J Proteomics 2013:760208","journal-title":"Int J Proteomics"},{"key":"16_CR53","doi-asserted-by":"publisher","first-page":"594761","DOI":"10.1155\/2014\/594761","volume":"2014","author":"S Kiprijanovska","year":"2014","unstructured":"Kiprijanovska S, Stavridis S, Stankov O, Komina S, Petrusevska G, Polenakovic M, Davalieva K (2014) Mapping and identification of the urine proteome of prostate cancer patients by 2D PAGE\/MS. Int J Proteomics 2014:594761","journal-title":"Int J Proteomics"},{"key":"16_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/B978-0-12-800094-6.00004-2","volume":"63","author":"J Beretov","year":"2014","unstructured":"Beretov J, Wasinger VC, Graham PH, Millar EK, Kearsley JH, Li Y (2014) Proteomics for breast cancer urine biomarkers. Adv Clin Chem 63:123\u2013167","journal-title":"Adv Clin Chem"},{"key":"16_CR55","first-page":"53","volume":"112C","author":"L Santucci","year":"2014","unstructured":"Santucci L, Candiano G, Petretto A, Bruschi M, Lavarello C, Inglese E, Righetti PG, Ghiggeri GM (2014) From hundreds to thousands: widening the normal human urinome (1). J Proteomics 112C:53\u201362","journal-title":"J Proteomics"},{"key":"16_CR56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.archoralbio.2008.08.007","volume":"54","author":"JD Rudney","year":"2009","unstructured":"Rudney JD, Staikov RK, Johnson JD (2009) Potential biomarkers of human salivary function: a modified proteomic approach. Arch Oral Biol 54:91\u2013100","journal-title":"Arch Oral Biol"},{"key":"16_CR57","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1021\/pr049911o","volume":"3","author":"PA Wilmarth","year":"2004","unstructured":"Wilmarth PA, Riviere MA, Rustvold DL, Lauten JD, Madden TE, David LL (2004) Two-dimensional liquid chromatography study of the human whole saliva proteome. J Proteome Res 3:1017\u20131023","journal-title":"J Proteome Res"},{"key":"16_CR58","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1021\/pr700764j","volume":"7","author":"P Denny","year":"2008","unstructured":"Denny P, Hagen FK, Hardt M, Liao L, Yan W, Arellanno M, Bassilian S, Bedi GS, Boontheung P, Cociorva D, Delahunty CM, Denny T, Dunsmore J, Faull KF, Gilligan J, Gonzalez-Begne M, Halgand F, Hall SC, Han X, Henson B, Hewel J, Hu S, Jeffrey S, Jiang J, Loo JA, Ogorzalek Loo RR, Malamud D, Melvin JE, Miroshnychenko O, Navazesh M, Niles R, Park SK, Prakobphol A, Ramachandran P, Richert M, Robinson S, Sondej M, Souda P, Sullivan MA, Takashima J, Than S, Wang J, Whitelegge JP, Witkowska HE, Wolinsky L, Xie Y, Xu T, Yu W, Ytterberg J, Wong DT, Yates JR 3rd, Fisher SJ (2008) The proteomes of human parotid and submandibular\/sublingual gland salivas collected as the ductal secretions. J Proteome Res 7:1994\u20132006","journal-title":"J Proteome Res"},{"key":"16_CR59","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/jnci\/djt007","volume":"105","author":"JP Gillet","year":"2013","unstructured":"Gillet JP, Varma S, Gottesman MM (2013) The clinical relevance of cancer cell lines. J Natl Cancer Inst 105:452\u2013458","journal-title":"J Natl Cancer Inst"},{"key":"16_CR60","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.2174\/138161209789649475","volume":"15","author":"W Zhang","year":"2009","unstructured":"Zhang W, Dolan ME (2009) Use of cell lines in the investigation of pharmacogenetic loci. Curr Pharm Des 15:3782\u20133795","journal-title":"Curr Pharm Des"},{"key":"16_CR61","doi-asserted-by":"publisher","first-page":"783131","DOI":"10.1155\/2013\/783131","volume":"2013","author":"D Paul","year":"2013","unstructured":"Paul D, Kumar A, Gajbhiye A, Santra MK, Srikanth R (2013) Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture. Biomed Res Int 2013:783131","journal-title":"Biomed Res Int"},{"key":"16_CR62","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0076-6879(07)38023-3","volume":"438","author":"U McDermott","year":"2008","unstructured":"McDermott U, Sharma SV, Settleman J (2008) High-throughput lung cancer cell line screening for genotype-correlated sensitivity to an EGFR kinase inhibitor. Methods Enzymol 438:331\u2013341","journal-title":"Methods Enzymol"},{"key":"16_CR63","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrc2820","volume":"10","author":"SV Sharma","year":"2010","unstructured":"Sharma SV, Haber DA, Settleman J (2010) Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer 10:241\u2013253","journal-title":"Nat Rev Cancer"},{"key":"16_CR64","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehar J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, Morais P, Meltzer J, Korejwa A, Jane-Valbuena J, Mapa FA, Thibault J, Bric-Furlong E, Raman P, Shipway A, Engels IH, Cheng J, Yu GK, Yu J, Aspesi P Jr, de Silva M, Jagtap K, Jones MD, Wang L, Hatton C, Palescandolo E, Gupta S, Mahan S, Sougnez C, Onofrio RC, Liefeld T, MacConaill L, Winckler W, Reich M, Li N, Mesirov JP, Gabriel SB, Getz G, Ardlie K, Chan V, Myer VE, Weber BL, Porter J, Warmuth M, Finan P, Harris JL, Meyerson M, Golub TR, Morrissey MP, Sellers WR, Schlegel R, Garraway LA (2012) The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483:603\u2013607","journal-title":"Nature"},{"key":"16_CR65","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/ijc.23844","volume":"123","author":"V Kulasingam","year":"2008","unstructured":"Kulasingam V, Diamandis EP (2008) Tissue culture-based breast cancer biomarker discovery platform. Int J Cancer 123:2007\u20132012","journal-title":"Int J Cancer"},{"key":"16_CR66","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrurol.2013.126","volume":"10","author":"MM Centenera","year":"2013","unstructured":"Centenera MM, Raj GV, Knudsen KE, Tilley WD, Butler LM (2013) Ex vivo culture of human prostate tissue and drug development. Nat Rev Urol 10:483\u2013487","journal-title":"Nat Rev Urol"},{"key":"16_CR67","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/prca.201300084","volume":"8","author":"MG Terp","year":"2014","unstructured":"Terp MG, Ditzel HJ (2014) Application of proteomics in the study of rodent models of cancer. Proteomics Clin Appl 8:640\u2013652","journal-title":"Proteomics Clin Appl"},{"key":"16_CR68","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1373\/clinchem.2009.140087","volume":"56","author":"FE Regnier","year":"2010","unstructured":"Regnier FE, Skates SJ, Mesri M, Rodriguez H, Tezak Z, Kondratovich MV, Alterman MA, Levin JD, Roscoe D, Reilly E, Callaghan J, Kelm K, Brown D, Philip R, Carr SA, Liebler DC, Fisher SJ, Tempst P, Hiltke T, Kessler LG, Kinsinger CR, Ransohoff DF, Mansfield E, Anderson NL (2010) Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration. Clin Chem 56:165\u2013171","journal-title":"Clin Chem"},{"key":"16_CR69","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/jnci\/djq306","volume":"102","author":"EP Diamandis","year":"2010","unstructured":"Diamandis EP (2010) Cancer biomarkers: can we turn recent failures into success? J Natl Cancer Inst 102:1462\u20131467","journal-title":"J Natl Cancer Inst"},{"key":"16_CR70","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jprot.2011.04.021","volume":"75","author":"J Cox","year":"2011","unstructured":"Cox J, Heeren RM, James P, Jorrin-Novo JV, Kolker E, Levander F, Morrice N, Picotti P, Righetti PG, Sanchez JC, Turck CW, Zubarev R, Alexandre BM, Corrales FJ, Marko-Varga G, O'Donovan S, O'Neil S, Prechl J, Simoes T, Weckwerth W, Penque D (2011) Facing challenges in proteomics today and in the coming decade: report of roundtable discussions at the 4th EuPA scientific meeting, Portugal, Estoril 2010. J Proteomics 75:4\u201317","journal-title":"J Proteomics"},{"key":"16_CR71","doi-asserted-by":"publisher","first-page":"967419","DOI":"10.4061\/2011\/967419","volume":"2011","author":"NS Wind","year":"2011","unstructured":"Wind NS, Holen I (2011) Multidrug resistance in breast cancer: from in vitro models to clinical studies. Int J Breast Cancer 2011:967419","journal-title":"Int J Breast Cancer"},{"key":"16_CR72","doi-asserted-by":"publisher","first-page":"8461","DOI":"10.1007\/s13277-014-2366-2","volume":"35","author":"L Zanotti","year":"2014","unstructured":"Zanotti L, Bottini A, Rossi C, Generali D, Cappelletti MR (2014) Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use. Tumour Biol 35:8461\u20138470","journal-title":"Tumour Biol"},{"key":"16_CR73","doi-asserted-by":"crossref","unstructured":"Pokharel D, Padula MP, Lu JF, Tacchi JL, Luk F, Djordjevic SP, Bebawy M (2014) Proteome analysis of multidrug-resistant, breast cancer-derived microparticles. J Extracell Vesicles 3","DOI":"10.3402\/jev.v3.24384"},{"key":"16_CR74","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.phymed.2014.06.013","volume":"21","author":"T Hu","year":"2014","unstructured":"Hu T, To KK, Wang L, Zhang L, Lu L, Shen J, Chan RL, Li M, Yeung JH, Cho CH (2014) Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza. Phytomedicine 21:1264\u20131272","journal-title":"Phytomedicine"},{"key":"16_CR75","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-2605.2003.00434.x","volume":"26","author":"T Jope","year":"2003","unstructured":"Jope T, Lammert A, Kratzsch J, Paasch U, Glander HJ (2003) Leptin and leptin receptor in human seminal plasma and in human spermatozoa. Int J Androl 26:335\u2013341","journal-title":"Int J Androl"},{"key":"16_CR76","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0140-6736(07)61612-2","volume":"370","author":"R Bogle","year":"2007","unstructured":"Bogle R, Wilkins M (2007) Treating acute myocardial infarction: something in the wind? Lancet 370:1461\u20131462","journal-title":"Lancet"},{"key":"16_CR77","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1039\/C3MB70428A","volume":"10","author":"S Chen","year":"2014","unstructured":"Chen S, Dong Q, Hu S, Cai J, Zhang W, Sun J, Wang T, Xie J, He H, Xing J, Lu J, Dong Y (2014) Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells. Mol Biosyst 10:294\u2013303","journal-title":"Mol Biosyst"},{"key":"16_CR78","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5483\/BMBRep.2004.37.1.035","volume":"37","author":"J Seo","year":"2004","unstructured":"Seo J, Lee KJ (2004) Post-translational modifications and their biological functions: proteomic analysis and systematic approaches. J Biochem Mol Biol 37:35\u201344","journal-title":"J Biochem Mol Biol"},{"key":"16_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-540-72910-5_1","volume-title":"Proteome research. Principles and practice","author":"M Wilkins","year":"2007","unstructured":"Wilkins M, Appel R (2007) Ten Years of the Proteome. In: Wilkins M, Appel R, Williams K, Hochstrasser D (eds) Proteome research. Principles and practice. Springer, Berlin, pp 1\u201313. doi: 10.1007\/978-3-540-72910-5_1"},{"key":"16_CR80","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.mrgentox.2010.08.019","volume":"722","author":"M Balasubramani","year":"2011","unstructured":"Balasubramani M, Nakao C, Uechi GT, Cardamone J, Kamath K, Leslie KL, Balachandran R, Wilson L, Day BW, Jordan MA (2011) Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF\/PAGE difference gel electrophoresis. Mutat Res 722:154\u2013164","journal-title":"Mutat Res"},{"key":"16_CR81","doi-asserted-by":"publisher","first-page":"5668","DOI":"10.1021\/pr100478u","volume":"9","author":"DH Lee","year":"2010","unstructured":"Lee DH, Chung K, Song JA, Kim TH, Kang H, Huh JH, Jung SG, Ko JJ, An HJ (2010) Proteomic identification of paclitaxel-resistance associated hnRNP A2 and GDI 2 proteins in human ovarian cancer cells. J Proteome Res 9:5668\u20135676","journal-title":"J Proteome Res"},{"key":"16_CR82","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1158\/1078-0432.CCR-09-1091","volume":"16","author":"JA Bauer","year":"2010","unstructured":"Bauer JA, Chakravarthy AB, Rosenbluth JM, Mi D, Seeley EH, De Matos Granja-Ingram N, Olivares MG, Kelley MC, Mayer IA, Meszoely IM, Means-Powell JA, Johnson KN, Tsai CJ, Ayers GD, Sanders ME, Schneider RJ, Formenti SC, Caprioli RM, Pietenpol JA (2010) Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Clin Cancer Res 16:681\u2013690","journal-title":"Clin Cancer Res"},{"key":"16_CR83","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.psyneuen.2009.05.008","volume":"34","author":"MS Flint","year":"2009","unstructured":"Flint MS, Kim G, Hood BL, Bateman NW, Stewart NA, Conrads TP (2009) Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a CDK-1-dependent pathway. Psychoneuroendocrinology 34:1533\u20131541","journal-title":"Psychoneuroendocrinology"},{"key":"16_CR84","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/cdd.2013.193","volume":"21","author":"G Tufo","year":"2014","unstructured":"Tufo G, Jones AW, Wang Z, Hamelin J, Tajeddine N, Esposti DD, Martel C, Boursier C, Gallerne C, Migdal C, Lemaire C, Szabadkai G, Lemoine A, Kroemer G, Brenner C (2014) The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma. Cell Death Differ 21:685\u2013695","journal-title":"Cell Death Differ"},{"key":"16_CR85","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/bjc.2013.687","volume":"110","author":"PN Teng","year":"2014","unstructured":"Teng PN, Wang G, Hood BL, Conrads KA, Hamilton CA, Maxwell GL, Darcy KM, Conrads TP (2014) Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes. Br J Cancer 110:123\u2013132","journal-title":"Br J Cancer"},{"key":"16_CR86","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/path.4199","volume":"230","author":"M Aichler","year":"2013","unstructured":"Aichler M, Elsner M, Ludyga N, Feuchtinger A, Zangen V, Maier SK, Balluff B, Schone C, Hierber L, Braselmann H, Meding S, Rauser S, Zischka H, Aubele M, Schmitt M, Feith M, Hauck SM, Ueffing M, Langer R, Kuster B, Zitzelsberger H, Hofler H, Walch AK (2013) Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria. J Pathol 230:410\u2013419","journal-title":"J Pathol"},{"key":"16_CR87","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1200\/JCO.1998.16.2.462","volume":"16","author":"S Sjogren","year":"1998","unstructured":"Sjogren S, Inganas M, Lindgren A, Holmberg L, Bergh J (1998) Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol 16:462\u2013469","journal-title":"J Clin Oncol"},{"key":"16_CR88","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol 31:3997\u20134013","journal-title":"J Clin Oncol"},{"key":"16_CR89","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1021\/pr101073s","volume":"10","author":"NW Bateman","year":"2011","unstructured":"Bateman NW, Sun M, Bhargava R, Hood BL, Darfler MM, Kovatich AJ, Hooke JA, Krizman DB, Conrads TP (2011) Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues. J Proteome Res 10:1323\u20131332","journal-title":"J Proteome Res"},{"key":"16_CR90","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1200\/JCO.2013.49.4757","volume":"32","author":"P Nuciforo","year":"2014","unstructured":"Nuciforo P, Thyparambil S, Garrido-Castro AC, Peg V, Prudkin L, Jimenez J, Hoos WA, Burrows J, Hembrough TA, Perez-Garcia JM, Cortes J, Scaltriti M (2014) Correlation of high levels of HER2 measured by multiplex mass spectrometry with increased overall survival in patients treated with anti-HER2-based therapy. J Clin Oncol 32:5 (suppl.; abstr. 649)","journal-title":"J Clin Oncol"},{"key":"16_CR91","unstructured":"Protocol-Online Two dimensional SDS-PAGE. http:\/\/www.protocol-online.org\/prot\/Molecular_Biology\/Protein\/Protein_Electrophoresis\/Two-Demensional_SDS-PAGE\/"},{"key":"16_CR92","unstructured":"BIO-RAD (2014) 2-D electrophoresis for proteomics. http:\/\/www.pmf.colostate.edu\/Protocols\/BioRad%202D%20manual.pdf"},{"key":"16_CR93","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1021\/pr0606878","volume":"6","author":"A Hannigan","year":"2007","unstructured":"Hannigan A, Burchmore R, Wilson JB (2007) The optimization of protocols for proteome difference gel electrophoresis (DiGE) analysis of preneoplastic skin. J Proteome Res 6:3422\u20133432","journal-title":"J Proteome Res"},{"key":"16_CR94","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-1-59745-281-6_14","volume":"519","author":"K Marcus","year":"2009","unstructured":"Marcus K, Joppich C, May C, Pfeiffer K, Sitek B, Meyer H, Stuehler K (2009) High-resolution 2DE. Methods Mol Biol 519:221\u2013240","journal-title":"Methods Mol Biol"},{"key":"16_CR95","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-1-61779-885-6_6","volume":"893","author":"C May","year":"2012","unstructured":"May C, Brosseron F, Chartowski P, Meyer HE, Marcus K (2012) Differential proteome analysis using 2D-DIGE. Methods Mol Biol 893:75\u201382","journal-title":"Methods Mol Biol"},{"key":"16_CR96","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-61779-573-2_2","volume":"854","author":"P Beckett","year":"2012","unstructured":"Beckett P (2012) The basics of 2D DIGE. Methods Mol Biol 854:9\u201319","journal-title":"Methods Mol Biol"},{"key":"16_CR97","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-1-61737-960-4_13","volume":"702","author":"P Scherp","year":"2011","unstructured":"Scherp P, Ku G, Coleman L, Kheterpal I (2011) Gel-based and gel-free proteomic technologies. Methods Mol Biol 702:163\u2013190","journal-title":"Methods Mol Biol"},{"key":"16_CR98","unstructured":"GE_Healthcare (2004) 2-D electrophoresis principles and methods. http:\/\/www.gelifesciences.com\/gehcls_images\/GELS\/Related%20Content\/Files\/1335426794335\/litdoc80642960_20140929120525.pdf"},{"key":"16_CR99","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.jprot.2011.05.040","volume":"74","author":"T Rabilloud","year":"2011","unstructured":"Rabilloud T, Lelong C (2011) Two-dimensional gel electrophoresis in proteomics: a tutorial. J Proteomics 74:1829\u20131841","journal-title":"J Proteomics"}],"container-title":["Methods in Molecular Biology","Cancer Drug Resistance"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3347-1_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T18:59:12Z","timestamp":1567623552000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3347-1_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933457","9781493933471"],"references-count":99,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3347-1_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2016]]}}}